Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 31, 2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndromeJ J Vehreschild, C Müller, F Farowski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2014
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in GermanyS M Heimann, M J G T Vehreschild, L Meintker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 14, 2018
Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, GermanyM Stecher, A Chaillon, A M Eis-Hübinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2013
Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)M J G T Vehreschild, J J Vehreschild, K Hübel, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2010
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohortJ J Vehreschild, M J G T Rüping, H Wisplinghoff, et al.
Pageof 5